Brasada Capital Management LP bought a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 8,551 shares of the conglomerate's stock, valued at approximately $1,629,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new stake in shares of Danaher in the second quarter worth $44,000. MidFirst Bank bought a new stake in shares of Danaher in the second quarter valued at approximately $46,000. Bell Investment Advisors Inc acquired a new stake in shares of Danaher in the second quarter worth $47,000. Fiduciary Financial Advisors bought a new position in Danaher during the second quarter worth $53,000. Finally, Solstein Capital LLC acquired a new position in Danaher during the 2nd quarter valued at $58,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms have issued reports on DHR. Royal Bank Of Canada raised their price target on shares of Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Wolfe Research lowered shares of Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. Guggenheim reduced their target price on shares of Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Evercore reaffirmed an "outperform" rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Finally, Piper Sandler initiated coverage on Danaher in a report on Thursday, June 11th. They set a "neutral" rating and a $200.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $228.91.
Check Out Our Latest Research Report on DHR
Danaher Price Performance
NYSE:DHR opened at $215.74 on Friday. The company has a 50-day moving average of $198.69 and a 200-day moving average of $192.35. The company has a market capitalization of $151.67 billion, a price-to-earnings ratio of 38.32, a PEG ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. During the same quarter in the previous year, the firm posted $0.77 earnings per share. The firm's revenue for the quarter was up 5.5% on a year-over-year basis. As a group, equities research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
